Back to Trades
Hsu Jason
DirectorCIK 0001895035
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Hsu Jason, Director, has disclosed $109.8K in transactions — all concentrated in Immix Biopharma, Inc. (IMMX). Data is sourced from official SEC Form 3, 4, and 5 filings.